Author

A. L. Berr

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:metabolomics· 1 Organism:mouse· 1

Frequent Co-Authors

A. Petrosky· 1 shared B. J. Horton· 1 shared B. W. Purow· 1 shared C. Koch· 1 shared D. Cimini· 1 shared F. F. Bafakih· 1 shared G. dos Santos· 1 shared G. F. Beeghly· 1 shared

Activity by Year

2020-2020 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioengineering

A. Petrosky

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

A patient-designed tissue-engineered model of the infiltrative glioblastoma microenvironment

R. C. Cornelison, J. X. Yuan, K. M. Tate, A. Petrosky, G. F. Beeghly, M. Bloomfield, S. R. Schwager, A. L. Berr, D. Cimini, F. F. Bafakih, J. W. Mandell, B. W. Purow, B. J. Horton, J. Munson

This study develops a patient-derived 3D tissue-engineered model of glioblastoma to assess invasion, proliferation, and stemness in response to fluid flow and glial interactions, finding CD71 expression better predicts drug efficacy than viability.

bioRxiv · Oct 2, 2020Bioengineering

Vimentin is Required for Tumor Progression and Metastasis in a Mouse Model of Non-Small Cell Lung Cancer

A. L. Berr, K. Wiese, G. dos Santos, J. Davis, C. Koch, K. R. Anekalla, M. Kidd, Y. Cheng, Y.-S. Hu, K. Ridge

This study shows that vimentin is essential for metastasis in a mouse model of non-small cell lung cancer, as its loss impairs epithelial-to-mesenchymal transition and oxidative stress response.

bioRxiv · Jun 4, 2020Cancer Biology